Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|December 22, 2009
Prognostic impact of thymidine phosphorylase expression in breast cancer--comparison of microarray and immunohistochemical dataE Ruckhäberle, T Karn, K Engels, et al.
BMC Pregnancy and Childbirth|May 5, 2021
Influence of the second stage of labor on maternal and neonatal outcomes in vaginal births after caesarean section: a multicenter study in GermanyG Gitas, L Proppe, A K Ertan, et al.
Geburtshilfe Und Frauenheilkunde|February 14, 2017
What Are the Advantages of 3D Cameras in Gynaecological Laparoscopy?S Baum, M Sillem, J T Ney, et al.
Breast (Edinburgh, Scotland)|October 3, 2006
Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor responseA Rody, T Karn, R Gätje, et al.
Journal of Cancer Research and Clinical Oncology|March 4, 2021
Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancerL C Hanker, A El-Balat, Z Drosos, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 7, 2006
Uterotubal transport disorder in adenomyosis and endometriosis--a cause for infertilityS Kissler, N Hamscho, S Zangos, et al.
British Journal of Cancer|August 26, 2010
Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancerM Ihnen, R M Wirtz, K T Kalogeras, et al.
Molecular and Cellular Pediatrics|July 31, 2024
Effects of multistrain Bifidobacteria and Lactobacillus probiotics on HMO compositions after supplementation to pregnant women at threatening preterm delivery: design of the randomized clinical PROMO trialA Welp, E Laser, K Seeger, et al.
British Journal of Cancer|October 20, 2012
Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancerS Darb-Esfahani, R Kronenwett, G von Minckwitz, et al.
Gynecologic Oncology|October 13, 2021
Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancerG E Konecny, A E Wahner Hendrickson, T M Davidson, et al.
Pageof 6